INTRODUCTION
============

Lamins are intermediate filament proteins in the nuclear lamina and the cellular matrix and are critical determinants of nuclear architecture. They are important regulators of gene expression through their involvement in signaling, transcription, and chromatin organization ([@b1-ajas-27-1-123-14]; [@b13-ajas-27-1-123-14]). Mutations in *Lmna* are responsible for more than ten different disorders, commonly referred to as "laminopathies". These diseases are characterized by tissue-specific (striated muscle, adipose tissue, peripheral nerve) or systemic effects (premature ageing syndromes). *Lmna* mutations cause autosomal-dominant Emery-Dreifuss muscular dystrophy (EDMD) and related diseases with dilated cardiomyopathies (DCM) that affect cardiac muscle and skeletal muscle to variable degrees ([@b4-ajas-27-1-123-14]; [@b15-ajas-27-1-123-14]). Other *Lmna* mutations affect adipose tissue or peripheral neurons, causing Dunnigan-type familial partial lipodystrophy (FPLD) ([@b5-ajas-27-1-123-14]; [@b21-ajas-27-1-123-14]; [@b3-ajas-27-1-123-14]) or Charcot-Marie-Tooth type 2B1 disease ([@b7-ajas-27-1-123-14]), respectively. Some *Lmna* mutations cause progeroid syndromes, which are characterized by features of accelerated aging ([@b8-ajas-27-1-123-14]; [@b2-ajas-27-1-123-14]). Remarkable progress has been made in unraveling the molecular pathophysiology underlying these disorders. However, the mechanism whereby different mutations in *Lmna* cause such diverse diseases remains a puzzle.

The first genetic model for the study of laminopathy was the *Lmna* knockout mouse, which has become one of the most frequently used models to determine relationships between physiological functions of nuclear lamins and their contribution to the molecular pathophysiology of laminopathies. This mouse model has provided profound insights into many different aspects of A-type lamin functions. These *Lmna* knockout mice appear normal at birth but develop severe muscular dystrophy and die within eight weeks (Jahn et al., 1999; [@b18-ajas-27-1-123-14]). In the first reported human *Lmna*-null case, a baby possessing a homozygous nonsense mutation in *Lmna*, with no detectable A-type lamin proteins, died after premature birth, exhibiting similar clinical features, severe joint contractures, muscular dystrophy, fibrosis and the absence of muscle fibers in the diaphragm ([@b14-ajas-27-1-123-14]). The resemblance of the baby's symptoms to conditions observed in laminopathic mice suggests that A-type lamins, although not essential for cell viability, are essential for human life.

Different mutations in *Lmna* can produce different diseases, involving the skeleton, muscle, fat and many types of cell and tissue abnormalities, prompting lamin A/C functional diversity. The *Lmna* gene deletion in mice is one of the most versatile animal models for lamin function, providing insights into various issues of A-type lamin function. How the *Lmna* gene functions and why gene deletions cause the observed bodily changes are not entirely clear. In the diagnostic process of many clinical diseases, a patient's serum constituents are measured to evaluate specific organ functions, including liver function, heart function, and/or renal function. These results will aid in the physician's diagnosis of disease. This article explores the changes in growth and serum biochemistry in C57BL/6 mice due to homozygous or heterozygous deletion of the *Lmna* gene. These changes of serological parameters can implicate the affected organs of mice, and provide an experimental basis for the elucidation of *Lmna* gene functions.

MATERIALS AND METHODS
=====================

Mouse models and *Lmna* genotyping
----------------------------------

*Lmna* knockout mice in a C57BL/6 genetic background were generated as described previously ([@b18-ajas-27-1-123-14]). *Lmna^+/−^* mice were kindly provided by Professor Collin Stewart and were used to establish a heterozygous breeding colony of mice with a null allele of *Lmna* to obtain *Lmna^−/−^*, *Lmna*^+/−^ and *Lmna^+/+^* (n = 10 per group). The mice were genotyped by PCR using genomic DNA obtained from the tail using the Manual Extraction DNA Purification Kit (Beyotime Institute of Biotechnology, China) with *Lmna* wild-type and mutant allele primers. The sequences of *Lmna* wild-type primers were 5′-GCT GAG TAC AAC CTG CGC TCA C-3′ and 5′-GTA GGA GCG GGT GAC TAG GTT G -3′. The sequences of the *Lmna* mutant allele primers were 5′-TGT GGA ATG TGT GCG AGG CCA G -3′ and 5′-GTA GGA GCG GGT GAC TAG GTT G -3′. The target fragments were amplified for 40 cycles with denaturing at 95°C for 40 s, annealing at 62°C for 40 s and extending at 72°C for 60 s.

Experimental procedures and mice breeding procedures were performed as stipulated by the guidelines on animal research of the Animal Research Ethic Committee of the Guangdong Medical College, China. Animal care personnel paired one male and one female mouse in individually-ventilated microisolator cages. Each morning, females were checked for a vaginal plug as a sign of mating. Plug-positive females were individually housed throughout gestation and were allowed to develop their pregnancies to term. At 3 weeks of age, offspring were weaned from their mothers, and the sexes caged separately. Up to five sibling mice were housed per cage after weaning. Each cage housing a breeding unit pair was allowed free access to Purina Rodent Chow and tap water *ad libitum*. They were maintained in a controlled environment at 25±3°C and 75±2% relatively humidity with a 12:00/12:00-h dark/light cycle.

Serum collection
----------------

The mice were divided into three groups according to their determined genotype. Each group contained 10 male mice, and the *Lmna*^−/−^ group contained an additional 10 female mice. Blood samples were obtained by retro-orbital phlebotomy, and the mice were sacrificed at 4 weeks of age. Blood was collected into serum tubes between 09:00 and 11:00 a.m. After 30 min incubation at room temperature, the samples were centrifuged for 10 min at 2,500 rpm to obtain the serum at 4°C. We observed only a few cases of hemolysis, which were excluded from the study. The isolated serum was stored at −80°C until analysis.

Determination of clinical chemical parameters
---------------------------------------------

Fifteen parameters were measured from a single serum sample using an Olympus AU640 autoanalyzer (Olympus, Hamburg, Germany) and adapted reagents from Olympus (Hamburg, Germany) at 37°C. Calibration and quality control of the machine were performed daily according to the manufacturer's protocols and using the calibration samples obtained from the manufacturer. The clinical chemistry screen included the following parameters: i) the glycolipid panel including GLU, TG, Chol, HDL and LDL; ii) the heart panel including CK and CK-MB; iii) the liver panel including ALT, AST, ALP, and TP; iv) the kidney panel including BUN, Cyc C, Cr, and UA.

Growth monitoring of mice and weighing of tissues ([@b19-ajas-27-1-123-14])
---------------------------------------------------------------------------

The body weights of *Lmna*^−/−^, *Lmna*^+/+^ and *Lmna*^+/−^ mice were observed once every 3 days beginning at birth (D1) and ending 4 weeks after birth (D28). The weights of various organs, including the brain, heart, liver, kidney, lung, spleen, thymus gland, testis and left gastrocnemius muscle, were also determined at the end of the growth observation, and the organs were stored in liquid nitrogen. Tissues were removed free of adhering tissue and washed with normal saline after the blood was collected from the mice. Excess moisture was absorbed by clean filters, and the tissues were weighed immediately.

Data handling and statistical analysis
--------------------------------------

Statistical analyses were performed with SPSS (v13.0). Mean values and standard deviations were calculated for each parameter. The results are expressed as the mean±SD, and differences between groups of mice were determined by Levene's t-test, the Satterthwaite t-test, the Student-Neuman-Keuls (SNK) test, or Dunnett's T3 test. P values less than 0.05 were considered statistically significant.

RESULTS
=======

*Lmna*^+/−^ litters follow normal Mendelian inheritance patterns
----------------------------------------------------------------

The polymerase chain reaction (PCR) was used to verify the genotype of the mice using two pairs of primers specific to the sequences in wild-type and mutant *Lmna*. The wild-type mice exhibited a band of 210 bp, heterozygous mice exhibited bands at both 210 bp and 230 bp, and a single band of 230 bp was observed in homozygous *Lmna* deletion mice. In total, 117 mice from 13 litters were tested, among which 29 were confirmed to be wild-type, 21 were homozygous and the remainder were heterozygous. This was roughly consistent with the proportions expected based on the principle of Mendelian inheritance regularity. [Figure 1](#f1-ajas-27-1-123-14){ref-type="fig"} shows a representative genotyping of a 10-mouse litter by electrophoresis. Mice No. 1, No. 6, and No. 10 were wild-type. No. 3 and No. 9 were homozygous for the *Lmna* deletion. The rest were heterozygous for the deletion of *Lmna*.

*Lmna* deficient mice had significantly decreased weights and increased the ratio of organ to body weight in most of tissues
----------------------------------------------------------------------------------------------------------------------------

To examine the effects of *Lmna* deficiency on mouse growth, we measured the body weights from *Lmna^+^*^/+^, *Lmna*^+/−^ and *Lmna*^−/−^mice. The results showed that *Lmna*^−/−^ mice had significantly decreased body weight compared with *Lmna*^+/+^ and *Lmna*^+/−^ mice ([Figure 2](#f2-ajas-27-1-123-14){ref-type="fig"}). At 28 days after birth, the body weight of *Lmna*^−/−^ mice were about one half of *Lmna*^+/+^ and *Lmna*^+/−^ mice, while no significant differences in the growth of *Lmna*^+/+^ and *Lmna*^+/−^ mice were observed. The tissue weights and the organ to body weight ratios from mice with different genotypes are shown in [Figure 3](#f3-ajas-27-1-123-14){ref-type="fig"} and [Figure 4](#f4-ajas-27-1-123-14){ref-type="fig"}. Compared with *Lmna*^+/+^ and *Lmna*^+/−^ mice, the brain to body weight ratios increased dramatically (p\<0.05) in *Lmna*^−/−^ mice, although there are no significant differences (p\>0.05) in the weights of the brain tissue from the three groups. In contrast, the organ (lung, kidneys, thymus and testis) to body weight ratio increased drastically (p\<0.05), although the absolute weight of four organs decreased (p\<0.05) in *Lmna*^−/−^ mice at 4 weeks of age. *Lmna*^−/−^ mice also had an elevated ratio for their muscle and hearts, while there were only significant differences between the heart to body weight ratio found in *Lmna*^+/−^ and *Lmna*^−/−^ mice (p\<0.05). A similar decrease in the weight of the lung and spleen (p\<0.05), but with a decrease in organ: body weight ratio as well, there were only significant differences between the spleen: body weight ratio found in *Lmna*^+/+^ and *Lmna*^−/−^ mice (p\<0.05). There were no significant differences between the tissue weights and the organ: body weight ratio found in *Lmna*^+/+^ and *Lmna*^+/−^ mice (p\>0.05).

*Lmna* deficient mice had significant changes in the levels of serum biochemical analytes
-----------------------------------------------------------------------------------------

To explore the effect of *Lmna* deficiency on metabolism, we measured blood biochemical parameters of the mice on the 28th day after their birth. Ten serum samples from each group were taken for 15 analyses including glycolipid metabolism, heart function, liver function, and kidney function tests. It was found that the level of ALT ([Table 1](#t1-ajas-27-1-123-14){ref-type="table"} and [Figure 5C](#f5-ajas-27-1-123-14){ref-type="fig"}) in *Lmna*^−/−^ mice was significantly higher than that of other 2 groups (p\<0.05). Compared with *Lmna*^+/+^ and *Lmna*^+/−^ mice, *Lmna*^−/−^ mice exhibited lower levels of glucose, cholesterol, HDL ([Figure 5A](#f5-ajas-27-1-123-14){ref-type="fig"}), ALP ([Figure 5C](#f5-ajas-27-1-123-14){ref-type="fig"}) and creatinine ([Figure 5D](#f5-ajas-27-1-123-14){ref-type="fig"}) (p\<0.05). The AST levels in *Lmna*^−/−^ mice were higher than *Lmna*^+/+^ mice, not those of *Lmna*^+/−^ mice, while LDL and CK-MB levels were significantly lower ([Figure 5B](#f5-ajas-27-1-123-14){ref-type="fig"}) (p\<0.05). There were no significant differences of triacylglycerols, creatine kinase, total protein, BUN, cystatin C and uric acidin *Lmna*^+/+^, *Lmna*^+/−^ and *Lmna*^−/−^ mice (p\>0.05). As expected, there were no significant difference of the 15 parameters in male and female mice (data not shown, p\>0.05).

DISCUSSION
==========

Newborn *Lmna* deficient mice were indistinguishable from heterozygous or wild-type mice. However, within 2 to 3 weeks, a reduction in their body weight was noticed, and this slower growth continued up to 4 weeks. Despite normal tooth development and the continued ability to eat, the growth of these mice had ceased. At week 4, their mean body weight was approximately 50% that of their wild-type or heterozygous littermates ([@b18-ajas-27-1-123-14]). Through genotyping, we also found that mouse growth was consistent with the growth rate reported by Sullivan ([@b18-ajas-27-1-123-14]). We found that the average body weights of *Lmna*^+/+^ and *Lmna*^+/−^mice were larger than *Lmna*^−/−^mice approximately 19 days after birth, and after 28 days, the average weights of *Lmna*^+/+^ and *Lmna*^+/−^ mice were approximately twice that of *Lmna*^−/−^ mice. We calculated and compared the weights of different organs from the three groups of mice and found that homozygous deletion of *Lmna* significantly decreased weights and increased the ratio of organ to body weight in most of tissues. These ratios increased in mutant mice may be due to organ functional increase or pathological enlargement. Combined with the biochemical indicators of different organs function and the former literature analysis ([@b20-ajas-27-1-123-14]), kidney may be functional increased while the heart is pathological enlarged.

Because the mice that are homozygous for the *Lmna* null allele began to display abnormal gait with a stiff walking posture at 3 to 4 weeks and all had died by the eighth week, we performed serological analyses of all mice at the age of 4 weeks while the animals were still in good health and were mobile. This time point was selected due to the short life-span of the homozygous mice, and it enabled us to observe changes in serum biochemistry that accompanied externally apparent phenotypic changes in *Lmna*^−/−^ mice. The serological changes may indicate which tissue dysfunctions occurred and led to the early death of *Lmna*^−/−^ mice. The heterozygotes were also apparently normal and did not exhibit premature mortality compared with their wild-type siblings.

To the best of our knowledge, this is the first comprehensive report of 13 blood biochemical parameters except for glucose and triacylglyceride ([@b6-ajas-27-1-123-14]) in *Lmna*^−/−^ and *Lmna*^+/−^ C57BL/6 mice. Our results were consistent with two parameters reported ([@b6-ajas-27-1-123-14]). Therefore, our data may aid in the evaluation of changes to metabolism in these experimental animals compared to control animals. Compared with previous reports, our data regarding wild-type C57BL/6 mice at 4 weeks of age demonstrated some similar results, while some parameters were higher or lower (Kubben et al., 2002; [@b17-ajas-27-1-123-14]; [@b23-ajas-27-1-123-14]; [@b12-ajas-27-1-123-14]). The discrepancies in the biochemical values might depend on differential feeding of the mice, the ages of the mice at the time when blood was taken, the sex of the mice, or the environmental conditions in the laboratory in which the mice were reared (Yan et al., 2004; [@b23-ajas-27-1-123-14]; [@b12-ajas-27-1-123-14]). In addition to the above-mentioned factors, the site of blood collection may play a substantial role in the variation of both the biochemical values and the clinical pathology results ([@b17-ajas-27-1-123-14]).

Although the numerical values of the total protein and triacylglyceride parameters of *Lmna*^−/−^ mice were less than those of other genotypes mice, the trend was not significantly different. Several other serum metabolic indicators that were measured showed lower levels in *Lmna^−/−^* mice compared to *Lmna^+/+^* mice, including glucose, cholesterol, HDL and LDL. Consistent with the observed weight reduction in *Lmna^−/−^* mice, glucose levels were significantly reduced in these animals. Our results suggested that not only lipoproteins diminished but also the level of glucose decreased in the disorders observed in *Lmna*^−/−^ mice. These changes may be the result of reduced hepatic glucose production because we found that the pyruvate carboxylase (Pcx), the first of the key enzymes involved in glyconeogenesis, in *Lmna^−/−^* mice was about 71.76% of the level in wild mice (data not shown). HDL is an independent cardiovascular risk factor and that an increase of HDL of only 10 mg/L leads to a risk reduction of 2% to 3% ([@b11-ajas-27-1-123-14]). Therefore HDL reduction also could accelerate coronary heart disease considerably in *Lmna*-deleted mice.

The level of creatine kinase was 1,913±737.4 U/L in *Lmna*^+/+^ mice and was the closest to the average value reported by Michael et al. ([@b17-ajas-27-1-123-14]) in which creatine kinase activity was 2,114±1,571 U/L. The similar results may be because the blood samples were collected via the same retro-orbital blood collection method, and this sampling method appears to have introduced inter-individual differences that skew the results. Therefore, we suggest that this method of blood sampling is not suitable for detection of kinase activity and it may also reduce the experimental significance of differences detected in mice of different genotypes. The isozyme CK-MB and AST value, two indices of cardiomyocyte damage, were significantly different between the *Lmna*^−/−^ and *Lmna*^+/+^ groups. The AST levels were higher than those of the *Lmna^+^*^/^*^+^* group, which most likely indicates that the *Lmna* deletion leads to myocardial injury or liver alterations in mice. The lower CK-MB levels may be due to myocardial hypoplasia in *Lmna^−/−^* mice.

ALT is a sensitive index that reflects liver injury. The ALT levels in *Lmna*^−/−^ mice were significantly higher than those of *Lmna*^+/+^ and *Lmna*^+/−^ mice (p\<0.05). Our results suggest that the liver organ function of 4-week-old *Lmna*^−/−^ mice may be affected by the degree of liver cell injury that is indicated by the increase in ALT level. Increased ALT levels may be caused by the damage of cardiac or skeletal muscle or other tissues. Liver damage can also lead to increased ALP, but in *Lmna*^−/−^ mice, ALP is reduced compared with the other two groups.

Creatinine, urea, uric acid and cystatin C serum analyses are used to evaluate kidney function ([@b16-ajas-27-1-123-14]). Urea is the primary parameter used to evaluate renal function. Recent research demonstrates that there is a high correlation between impaired renal function and cystatin C concentrations in the serum, which can reflect changes in the human glomerular filtration rate (GFR). These tests are used as early diagnostic tools for diabetic nephropathy and hypertension-associated renal damage. The serum concentrations of urea, cystatin C and uric acid showed no significant differences among the three different *Lmna* genotypes in the mice from this study. However, creatinine is a less sensitive evaluation index for renal function and was obviously lower in *Lmna*^−/−^ mice than in *Lmna*^+/+^ and *Lmna*^+/−^ mice, which may suggest that renal function has not been damaged in *Lmna*^−/−^ mice. The reduction in serum creatinine may be due to muscle hypoplasia in *Lmna^−/−^* mice because creatinine is a metabolic end-product of muscle creatine and phosphocreatine consumption, and its production is proportional to muscle mass.

In conclusion, the deletion of the *Lmna* gene not only affects the growth and development of C57BL/6 mice but also altered their serological biochemistry. Homozygous deletions of the *Lmna* gene can lead to impaired heart and liver function, as well as glucose and lipid metabolism disorders.
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![Genotyping of *Lmna* in the mice. PCR was applied to detect the *Lmna* allele in the mice. The upper bands indicate wild-type alleles. The lower bands indicate mice that possess the *Lmna* homozygous deletion. Mice with both bands are heterozygous. M = DL2000 Marker. 1--10 = PCR amplification products from mice No. 1 to No. 10. P = Positive control. N = Negative control.](ajas-27-1-123-14f1){#f1-ajas-27-1-123-14}

![Growth curves of mice with different *Lmna* genotypes. The body weights of *Lmna*^−/−^, *Lmna*^+/+^ and *Lmna*^+/−^ mice were evaluated once every 3 days from their birth (D1) to 4 weeks (D28). The data are presented as the mean±SD, n = 30. The black solid line denotes wild-type mice. The long dashed line denotes *Lmna*^+/−^ mice. The short dashed line indicates *Lmna^−/−^* mice. \* p\<0.05.](ajas-27-1-123-14f2){#f2-ajas-27-1-123-14}

![Tissue weights of *Lmna*^+/+^, *Lmna*^+/−^ and *Lmna*^−/−^ mice. Most tissue weights of *Lmna*-deleted mice at 4 weeks after birth were decreased. The data are presented as the mean±SD, n = 30. \*\* Indicates p\<0.01.](ajas-27-1-123-14f3){#f3-ajas-27-1-123-14}

![The ratio of organ to body weight in *Lmna*^+/+^, *Lmna*^+/−^ and *Lmna*^−/−^ mice. *Lmna*^−/−^ mice at 4 weeks displayed increased ratio of organ to body weight in most of tissues. The data are presented as the mean±SD, n = 30. \* Indicates p\<0.05; \*\* Indicates p\<0.01; \*\*\* Indicates p\<0.001.](ajas-27-1-123-14f4){#f4-ajas-27-1-123-14}

![Blood biochemical values of *Lmna*^+/+^, *Lmna*^+/−^ and *Lmna*^−/−^ mice. (A) Glycolipid metabolism correlation index; (B) Cardiac function indicators; (C) Liver function indices; (D) Renal function indices. The data are presented as the mean±SD, n = 30. \* Indicates p\<0.05; \*\* Indicates p\<0.001.](ajas-27-1-123-14f5){#f5-ajas-27-1-123-14}

###### 

Serum biochemical analytes (mean±SD) measured in C57BL/6 mice with the genotypes *Lmna*^+/+^, *Lmna*^+/−^ and *Lmna*^−/−^

  Biochemical indexes                                             *Lmna*^+/+^   *Lmna*^+/−^     *Lmna*^−/−^      P(SNK)                                                                                                                
  --------------------------------------------------------------- ------------- --------------- ---------------- ---------------------------------------------------------- ---------------------------------------------------------- -------
  GLU (mmol/L)                                                    6.82±1.09     7.09±0.93       3.13±0.78        0.000[\*\*](#tfn4-ajas-27-1-123-14){ref-type="table-fn"}   0.000[\*\*](#tfn4-ajas-27-1-123-14){ref-type="table-fn"}   1.000
  Chol[1](#tfn1-ajas-27-1-123-14){ref-type="table-fn"} (mmol/L)   2.92±0.21     2.74±0.26       2.02±0.42        0.000[\*\*](#tfn4-ajas-27-1-123-14){ref-type="table-fn"}   0.000[\*\*](#tfn4-ajas-27-1-123-14){ref-type="table-fn"}   0.560
  TG (mmol/L)                                                     1.38±0.61     1.61±1.01       1.3±0.57         1.000                                                      1.000                                                      1.000
  HDL (mmol/L)                                                    2.17±0.15     2.07±0.26       1.38±0.21        0.000[\*\*](#tfn4-ajas-27-1-123-14){ref-type="table-fn"}   0.000[\*\*](#tfn4-ajas-27-1-123-14){ref-type="table-fn"}   0.907
  LDL (mmol/L)                                                    0.7±0.07      0.63±0.16       0.53±0.10        0.010[\*](#tfn3-ajas-27-1-123-14){ref-type="table-fn"}     0.173                                                      0.700
  CK (U/L)                                                        1,913±737.4   1,838.2±406.8   1,461.9±383.88   0.210                                                      0.381                                                      1.000
  CK-MB (U/L)                                                     784.6±286.8   529.7±105.34    489.4±149.48     0.013[\*](#tfn3-ajas-27-1-123-14){ref-type="table-fn"}     1.000                                                      0.117
  ALT (U/L)                                                       39.2±10.21    37.6±8.3        54.1±6.4         0.002[\*\*](#tfn4-ajas-27-1-123-14){ref-type="table-fn"}   0.001[\*\*](#tfn4-ajas-27-1-123-14){ref-type="table-fn"}   1.000
  AST (U/L)                                                       110.4±21.86   120.8±44.6      145.4±14.37      0.043[\*](#tfn3-ajas-27-1-123-14){ref-type="table-fn"}     0.229                                                      1.000
  ALP (U/L)                                                       340.6±53.85   297±56.62       200.1±49.98      0.000[\*\*](#tfn4-ajas-27-1-123-14){ref-type="table-fn"}   0.001[\*\*](#tfn4-ajas-27-1-123-14){ref-type="table-fn"}   0.239
  TP (g/L)                                                        50.12±2.03    48.63±2.23      47.86±2.22       0.081                                                      1.000                                                      0.406
  CR (μmol/L)                                                     31.9±3.96     28\. 6±2.32     22.2±3.05        0.000[\*\*](#tfn4-ajas-27-1-123-14){ref-type="table-fn"}   0.000[\*\*](#tfn4-ajas-27-1-123-14){ref-type="table-fn"}   0.084
  BUN (mmol/L)                                                    7.26±1.27     6.74±0.89       7.3±1.22         1.000                                                      0.866                                                      0.973
  UA (μmol/L)                                                     90.6±16.65    86.5±16.19      101.4±14.16      0.407                                                      0.130                                                      1.000
  Cys C (mg/L)                                                    0.77±0.17     0.66±0.09       0.64±0.2         0.244                                                      1.000                                                      0.381

Denotes variances determined using Dunnett′s T3 test; others were determined using the Student-Neuman-Keuls test.

Statistically significant differences among the values observed in the three groups (*Lmna*^+/+^, *Lmna*^+/−^, and *Lmna*^−/−^) are also indicated as follows:

p\<0.05;

p\<0.001.
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